These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 33672232)
1. Macrophage Function and the Role of GSK3. Patel S; Werstuck GH Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672232 [TBL] [Abstract][Full Text] [Related]
2. Inhibiting Glycogen Synthase Kinase 3 Reverses Obesity-Induced White Adipose Tissue Inflammation by Regulating Apoptosis Inhibitor of Macrophage/CD5L-Mediated Macrophage Migration. Wang L; Wang Y; Zhang C; Li J; Meng Y; Dou M; Noguchi CT; Di L Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2103-2116. PubMed ID: 30026270 [TBL] [Abstract][Full Text] [Related]
3. Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases. Wang L; Li J; Di LJ Med Res Rev; 2022 Mar; 42(2):946-982. PubMed ID: 34729791 [TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase 3: more than a namesake. Rayasam GV; Tulasi VK; Sodhi R; Davis JA; Ray A Br J Pharmacol; 2009 Mar; 156(6):885-98. PubMed ID: 19366350 [TBL] [Abstract][Full Text] [Related]
6. GSK3: A Kinase Balancing Promotion and Resolution of Inflammation. Hoffmeister L; Diekmann M; Brand K; Huber R Cells; 2020 Mar; 9(4):. PubMed ID: 32231133 [TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Wang H; Brown J; Martin M Cytokine; 2011 Feb; 53(2):130-40. PubMed ID: 21095632 [TBL] [Abstract][Full Text] [Related]
12. Hyperactivity: glycogen synthase kinase-3 as a therapeutic target. Mines MA Eur J Pharmacol; 2013 May; 708(1-3):56-9. PubMed ID: 23500205 [TBL] [Abstract][Full Text] [Related]
13. Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes. Wagman AS; Johnson KW; Bussiere DE Curr Pharm Des; 2004; 10(10):1105-37. PubMed ID: 15078145 [TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease. Golpich M; Amini E; Hemmati F; Ibrahim NM; Rahmani B; Mohamed Z; Raymond AA; Dargahi L; Ghasemi R; Ahmadiani A Pharmacol Res; 2015 Jul; 97():16-26. PubMed ID: 25829335 [TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase 3 beta is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1). Kim JW; Lee JE; Kim MJ; Cho EG; Cho SG; Choi EJ J Biol Chem; 2003 Apr; 278(16):13995-4001. PubMed ID: 12584189 [TBL] [Abstract][Full Text] [Related]
16. GSK3 takes centre stage more than 20 years after its discovery. Frame S; Cohen P Biochem J; 2001 Oct; 359(Pt 1):1-16. PubMed ID: 11563964 [TBL] [Abstract][Full Text] [Related]
17. Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1/SREBP1c. Kim KH; Song MJ; Yoo EJ; Choe SS; Park SD; Kim JB J Biol Chem; 2004 Dec; 279(50):51999-2006. PubMed ID: 15466874 [TBL] [Abstract][Full Text] [Related]
18. Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors. Wadhwa P; Jain P; Jadhav HR Curr Top Med Chem; 2020; 20(17):1522-1534. PubMed ID: 32416693 [TBL] [Abstract][Full Text] [Related]
19. A role for glycogen synthase kinase-3 in antagonizing mycobacterial immune evasion by negatively regulating IL-10 induction. Chan MM; Cheung BK; Li JC; Chan LL; Lau AS J Leukoc Biol; 2009 Aug; 86(2):283-91. PubMed ID: 19401395 [TBL] [Abstract][Full Text] [Related]
20. GSK3β is increased in adipose tissue and skeletal muscle from women with gestational diabetes where it regulates the inflammatory response. Lappas M PLoS One; 2014; 9(12):e115854. PubMed ID: 25541965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]